Chi-Med announced today that solepinib has been certified as an orphan drug by the US Food and Drug Administration to treat autoimmune hemolytic anemia. Solepinib is a novel, highly selective oral spleen tyrosine kinase inhibitor.

Zhitongcaijing · 2d ago
Chi-Med announced today that solepinib has been certified as an orphan drug by the US Food and Drug Administration to treat autoimmune hemolytic anemia. Solepinib is a novel, highly selective oral spleen tyrosine kinase inhibitor.